What is the current Price Target for the Immunovant Inc stock?

The average Immunovant Inc target price is $45.39. This is 139.65% higher than the current stock price. The highest price target is 216.00%, the lowest is -14.68%. 15 Analysts have issued a price target Immunovant Inc 2026 .

How high will the Immunovant Inc stock rise?

No reliable answer can be given as to how high the Immunovant Inc stock will rise. The performance of stocks, including the Immunovant Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Immunovant Inc stock today?

The performance of Immunovant Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Immunovant Inc stock fall?

The decline in Immunovant Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Immunovant Inc Forecast, price target & analysts

$18.94

1.07%

Nasdaq, Oct 24, 10:00 pm CET

ISIN

US45258J1025

Symbol

IMVT

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Immunovant Inc Target price 2025 - Analyst rating & recommendation

Immunovant Inc Classifications & Recommendation:

Buy

77%

Hold

23%

Immunovant Inc Price Target

Target Price	$45.39
Price	$18.94
Potential	139.65% register free of charge
Number of Estimates	15

	15 Analysts have issued a price target Immunovant Inc 2026 . The average Immunovant Inc target price is $45.39. This is 139.65% register free of charge higher than the current stock price. The highest price target is $59.85 216.00% register free of charge , the lowest is $16.16 14.68% register free of charge .
	A rating was issued by 22 analysts: 17 Analysts recommend Immunovant Inc to buy, 5 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Immunovant Inc stock has an average upside potential 2026 of 139.65% register free of charge . Most analysts recommend the Immunovant Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2032

Create a premium account to unlock analyst estimates. Learn more

Annually

	Mar '25	2026 Estimates
Earnings Per Share $	-2.73	-3.01
	45.21%	10.26%
P/E		negative

16 Analysts have issued a Immunovant Inc forecast for earnings per share. The average Immunovant Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2025	$-2.73	45.21%
2026	$-3.01 10.26% Unlock
2027	$-3.00 0.33% Unlock
2028	$-2.67 11.00% Unlock
2029	$-1.11 58.43% Unlock
2030	$3.87 448.65% Unlock
2031	$15.77 307.49% Unlock
2032	$21.88 38.74% Unlock

Current	-7.26	45.58%
2026	-6.29 13.32% Unlock
2027	-6.31 0.32% Unlock
2028	-7.10 12.52% Unlock
2029	-17.00 139.44% Unlock
2030	4.89 128.76% Unlock
2031	1.20 75.46% Unlock
2032	0.87 27.50% Unlock

Immunovant Inc...

Current Immunovant Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Truist Securities	Locked ➜ Locked	Locked	Oct 14 2025
JP Morgan	Locked ➜ Locked	Locked	Sep 30 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Sep 04 2025
B of A Securities	Locked ➜ Locked	Locked	Aug 12 2025
JP Morgan	Locked ➜ Locked	Locked	Aug 12 2025
UBS	Locked ➜ Locked	Locked	Jul 28 2025
UBS	Locked ➜ Locked	Locked	Apr 22 2025

Analyst Rating	Date
Locked Truist Securities: Locked ➜ Locked	Oct 14 2025
Locked JP Morgan: Locked ➜ Locked	Sep 30 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Sep 04 2025
Locked B of A Securities: Locked ➜ Locked	Aug 12 2025
Locked JP Morgan: Locked ➜ Locked	Aug 12 2025
Locked UBS: Locked ➜ Locked	Jul 28 2025
Locked UBS: Locked ➜ Locked	Apr 22 2025

Discover more stocks with a high price target

TUI 50.73%

Deutsche Telekom 33.66%

Netflix 32.31%

BioNTech SE - ADR 32.25%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now